Benzinga | Oct 13, 2020 06:38AM EDT

Jefferies Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $30

Jefferies initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $30.